BETULIN AS A PROMISING SOURCE FOR OBTAINING ANTIVIRAL DRUGS

Authors

  • A.V. Pereslavtseva Институт технической химии УрО РАН
  • N.V. Galaiko Институт технической химии УрО РАН

DOI:

Keywords:

betulin, 2,3-secotriterpenoids, HIV, herpes, influenza, polytarget properties

Abstract

The perspective of researching the development of effective antiviral drugs on the basis of semi- synthetic derivatives of natural origin pentacyclic triterpenoid betulin is discussed in the article. Significant attention is paid to estimating the possibility of using the triterpene derivatives to suppress the multiplication of enveloped viruses that cause socially dangerous infectious diseases – influenza, herpes, and HIV.

Supporting Agencies
Работа выполнена при финансовой поддержке программы Президиума РАН «Фундаментальные науки – медицине» (грант № 12-P-3-1009) и грантов РФФИ № 12-03-31060_мол_а, 10-03-96044-р_урал_а.

Author Biographies

  • A.V. Pereslavtseva, Институт технической химии УрО РАН
    аспирант
  • N.V. Galaiko, Институт технической химии УрО РАН
    кандидат химических наук, младший научный сотрудник

References

  1. Analiz naibolee perspektivnyh issledovanij po sozdaniu novyh lekarstvennyh sredstv / V.P. Fisenko, A.P. Drozzin, M.T. Abidov [i dr.] - NCEGKLS, 2000. - 47 s.
  2. Betulin i ego proizvodnye. himia i biologiceskaa aktivnost’ / G.A. Tolstikov, O.B. Flehter, E.E. Sul’c, L.A. Baltina, A.G. Tolstikov // Himia v interesah ustojcivogo razvitia. - 2005. - T. 13. - S. 1-30.
  3. Borc M.S., Nikolaeva E.G., Laevskij I.S. // Sposob vydelenia betulinola. Patent RF No 2206572, 20.06.2003.
  4. Grisko V.V., Tolmaceva I.A., Krajnova G.F., Nazarov A.V. // Sposob polucenia A-sekotriterpenovyh S-3(28) mono- i diamidov i ih seko-intermediatov. Zaavka na patent RF No 2013120593.
  5. Ersov F.I. Antivirusnye preparaty. - M.: Medicina, 1998. - 187 s.
  6. Ersov F.I. Sistema interferona v norme i pri patologii. - M.: Medicina, 1998, - 140 s.
  7. Ersov F.I., Malinovskaa V.V. Immunomodulatory v profilaktike i terapii virusnyh infekcij // ZMEI. - 1996. - No 3. - S. 122-125.
  8. Kuznecov B.N., Levdanskij V.A., Silkina T.A., Repah S.M. // Sposob polucenia betulina. Patent RF No 2074867, 10.03.1997.
  9. Levdanskij V.A., Levdanskij A.V., Kuznecov B.N. // Sposob polucenia betulina. Patent RF No 2340624, 11.07.2007.
  10. Levdanskij V.A., Polezaeva N.I., Es’kin A.P., Vink V.A., Kuznecov B.N. // Sposob polucenia betulina. Patent RF No 2131882, 20.06.1999.
  11. Rosin V.I., Sabanova N.U., Vedernikov D.N. // Sposob polucenia betulina. Patent RF No 2184120, 27.06.2002.
  12. Sintez i protivovirusnaa aktivnost’ 2,3-seko-proizvodnyh betulonovoj kisloty / I.A. Tolmaceva, V.V. Grisko, E.I. Boreko, O.V. Savinova, N.I. Pavlova // Himia prirod. soed. - 2009. - T. 45. - S. 566-568.
  13. Sintez lupanovyh i 19b,28-epoksi-18a-oleananovyh 2,3-seko-proizvodnyh na osnove betulina / I.A. Tolmaceva, A.V. Nazarov, O.A. Majorova, V.V. Grisko // Himia prirod. soed. - 2008. - T. 44. - S. 491-494.
  14. Sirotkin G.V., Sternin U.I. // Sposob polucenia betulina. Patent RF No 2172178, 20.08.2001.
  15. Terpenoidy lupana - biologiceskaa aktivnost’ i farmakologiceskie perspektivy. 1. Prirodnye proizvodnye lupana. 1 cast’ / T.G. Tolstikova, KV. Sorokina, G.A. Tolstikov [i dr.] // Bioorg. himia. - 2006. - T. 32. - S. 42-55.
  16. Terpenoidy lupana - biologiceskaa aktivnost’ i farmakologiceskie perspektivy. Polusinteticeskie proizvodnye lupana. 2 cast’ / T.G. Tolstikova, KV. Sorokina, G.A. Tolstikov [i dr.] // Bioorg. himia. - 2006. - T. 32. - S. 291-307.
  17. Anti-AIDS agents-XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives / F. Hashimoto, Y. Kashiwada, L.M. Cosentino, C.H. Chen, P.E. Garrett, K.H. Lee // Bioorg. Med. Chem. - 1997. - Vol. 5. - P. 2133-2143.
  18. Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry / F. Soler, C. Poujade, M. Evers, J.C. Carry, Y. Henin, A. Bousseau, T. Huet, R. Pauwels, E. De Clercq, J.F. Mayaux, J.B. Le Perq, N. Dereu // J. Med. Chem. - 1996. - Vol. 39. - P. 1069-1083.
  19. Cichewicz R.H., Kouzi S.A. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection // Med. Res. Rev. - 2004. - Vol. 24. - P. 90-114.
  20. Huang L., Ho P., Lee K.H., Chen C.H. Synthesis and anti-HIV activity of bi- finctional betulinic acid derivatives // Bioorg. Med. Chem. - 2006. - Vol. 14. - P. 2279-2289.
  21. PA457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing / F. Li, R. Goila-Gaur, K. Salzwedel, N.R. Kilgore, M. Reddick, C. Matallana, A. Castillo, D. Zoumplis, D.E. Martin, J.M. Orenstein, G.P. Allaway, E.O. Freed, C.T. Wild // Proc. Natl Acad. Sci. USA. - 2003. - Vol. 100. - P. 13555-13560.
  22. Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open- label, parallel-group study / D.E. Martin, H. Galbraith, J. Schettler, C. Ellis, J. Doto // Clin. Ther. - 2008. - Vol. 30. - P. 1794-1805.
  23. The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV / D. Yu, C.T. Wild, D.E. Martin, S.L. Morris-Natschke, C.H. Chen, G.P. Allaway, K.H. Lee // Expert Opin. Inv. Drugs. - 2005. - Vol. 14. - P. 681-693.

Downloads

Published

2014-01-15

Issue

No. 3 (2013)

Section

Research: theory and experiment

How to Cite

Pereslavtseva, A. ., & Galaiko, N. . (2014). BETULIN AS A PROMISING SOURCE FOR OBTAINING ANTIVIRAL DRUGS. Perm Federal Research Centre Journal, 3, 34-41. https://journal.permsc.ru/index.php/pscj/article/view/PSCJ2013n3p4